AI assistant
DAVITA INC. — Director's Dealing 2014
Nov 24, 2014
30643_dirs_2014-11-24_edbbe242-8a0c-43a4-85c5-32e0610b5269.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DAVITA HEALTHCARE PARTNERS INC. (DVA)
CIK: 0000927066
Period of Report: 2014-11-20
Reporting Person: Margolis Robert J (Director, Co-Chairman of the Board)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-11-20 | Common Stock | S | 15700 | $75.0448 | Disposed | 2801794 | Indirect |
| 2014-11-21 | Common Stock | S | 15700 | $75.1245 | Disposed | 2786094 | Indirect |
Footnotes
F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2014.
F2: Represents the weighted average sale price of $75.0448. The range of prices for the sale of these shares was $74.80 - $75.24, rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
F3: Represents the weighted average sale price of $75.1245. The range of prices for the sale of these shares was $75.25 - $75.41, rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
F4: Robert and Lisa Margolis Family Trust, 7/27/2000.